Entity Details

Primary name CO3A1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP02461
EntryNameCO3A1_HUMAN
FullNameCollagen alpha-1(III) chain
TaxID9606
Evidenceevidence at protein level
Length1466
SequenceStatuscomplete
DateCreated1986-07-21
DateModified2021-06-02

Ontological Relatives

GenesCOL3A1

GO terms

Show/Hide Table
GOName
GO:0001501 skeletal system development
GO:0002020 protease binding
GO:0005178 integrin binding
GO:0005201 extracellular matrix structural constituent
GO:0005576 extracellular region
GO:0005586 collagen type III trimer
GO:0005615 extracellular space
GO:0005788 endoplasmic reticulum lumen
GO:0007160 cell-matrix adhesion
GO:0007179 transforming growth factor beta receptor signaling pathway
GO:0007229 integrin-mediated signaling pathway
GO:0007507 heart development
GO:0009314 response to radiation
GO:0009612 response to mechanical stimulus
GO:0018149 peptide cross-linking
GO:0021987 cerebral cortex development
GO:0030020 extracellular matrix structural constituent conferring tensile strength
GO:0030168 platelet activation
GO:0030198 extracellular matrix organization
GO:0030199 collagen fibril organization
GO:0031012 extracellular matrix
GO:0034097 response to cytokine
GO:0035025 positive regulation of Rho protein signal transduction
GO:0042060 wound healing
GO:0043588 skin development
GO:0046872 metal ion binding
GO:0048407 platelet-derived growth factor binding
GO:0050776 regulation of immune response
GO:0050777 negative regulation of immune response
GO:0062023 collagen-containing extracellular matrix
GO:0097435 supramolecular fiber organization
GO:2001223 negative regulation of neuron migration

Subcellular Location

Show/Hide Table
Subcellular Location
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR000885 Fibrillar collagen, C-terminalDomainDomain
IPR001007 VWFC domainDomainDomain
IPR008160 Collagen triple helix repeatRepeatRepeat

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618343 OMIMPolymicrogyria with or without vascular-type Ehlers-Danlos syndrome (PMGEDSV)An autosomal recessive disorder with a highly variable phenotype and onset in early childhood. Disease features include cobblestone-like malformation of the cortex, polymicrogyria, intellectual and motor developmental delay, small joint hypermobility, vascular fragility, aneurysms, thin translucent skin and easy bruising, congenital heart defects, and foot deformities. Early death due to vascular dissection may occur. The disease is caused by variants affecting the gene represented in this entry.
130050 OMIMEhlers-Danlos syndrome, vascular type (EDSVASC)A severe form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSVASC is an autosomal dominant disease characterized by joint and dermal manifestations as in other forms of the syndrome, and by proneness to spontaneous rupture of bowel and large arteries. The vascular complications may affect all anatomical areas. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00048 Collagenase clostridium histolyticumDrugbankbiotech